120 related articles for article (PubMed ID: 11430449)
1. Osteoporosis in men.
Cefalu CA
Am Fam Physician; 2001 Jun; 63(12):2331-2. PubMed ID: 11430449
[No Abstract] [Full Text] [Related]
2. Gender differences in osteoporosis treatment: a review of clinical research.
Crandall C
J Gend Specif Med; 2000; 3(8):42-6. PubMed ID: 11253267
[TBL] [Abstract][Full Text] [Related]
3. [Osteoporosis in men].
Ringe JD
Dtsch Med Wochenschr; 2003 Apr; 128(17):925-8. PubMed ID: 12715292
[No Abstract] [Full Text] [Related]
4. [Risedronate, a new diphosphonate in osteoporosis and Paget's disease].
Bannwarth B
Presse Med; 2002 Mar; 31(8):340-2. PubMed ID: 11913075
[No Abstract] [Full Text] [Related]
5. [Osteoporosis treatment: choices and options].
Reginster JY
Pol Arch Med Wewn; 2007 Jul; 117(7):283-4. PubMed ID: 17966592
[No Abstract] [Full Text] [Related]
6. Bisphosphonates. A cornerstone of osteoporosis treatment.
Mayo Clin Womens Healthsource; 2007 May; 11(5):1-2. PubMed ID: 17476171
[No Abstract] [Full Text] [Related]
7. Risedronate for the prevention and treatment of corticosteroid-induced osteoporosis.
Dougherty JA
Ann Pharmacother; 2002 Mar; 36(3):512-6. PubMed ID: 11895066
[TBL] [Abstract][Full Text] [Related]
8. [Evidence-based therapy of osteoporosis--comment on DMW 17/2003].
Traut V
Dtsch Med Wochenschr; 2003 Jul; 128(30):1618; author reply 1618. PubMed ID: 12884153
[No Abstract] [Full Text] [Related]
9. Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study.
Rosen CJ; Hochberg MC; Bonnick SL; McClung M; Miller P; Broy S; Kagan R; Chen E; Petruschke RA; Thompson DE; de Papp AE;
J Bone Miner Res; 2005 Jan; 20(1):141-51. PubMed ID: 15619680
[TBL] [Abstract][Full Text] [Related]
10. Osteoporosis: diagnosis, prevention, and treatment of established disease.
Dunlop MB; Lane NE
Bull Rheum Dis; 1999; 48(6):1-4. PubMed ID: 10544524
[No Abstract] [Full Text] [Related]
11. [Osteoporosis in the patients with rheumatoid arthritis (3) : the efficacy and the selection of the osteoporosis therapeutic drug].
Nakayama H
Clin Calcium; 2007 Oct; 17(10):1607-12. PubMed ID: 17906416
[TBL] [Abstract][Full Text] [Related]
12. Iatrogenic osteoporosis.
Hamdy RC
South Med J; 1999 Nov; 92(11):1131-3. PubMed ID: 10586849
[No Abstract] [Full Text] [Related]
13. Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date.
Hodsman AB; Hanley DA; Josse R
CMAJ; 2002 May; 166(11):1426-30. PubMed ID: 12054412
[No Abstract] [Full Text] [Related]
14. Bisphosphonates in the treatment of osteoporosis. Principles and efficacy.
Papapoulos SE
Ann Med Interne (Paris); 2000 Oct; 151(6):504-10. PubMed ID: 11104931
[No Abstract] [Full Text] [Related]
15. Is the increase in osteoporosis prevention a result of the audit?
Naunton M
Clin Neurol Neurosurg; 2006 Oct; 108(7):718-9. PubMed ID: 16621242
[No Abstract] [Full Text] [Related]
16. [FACT study: benefits of alendronate].
MMW Fortschr Med; 2005 Jan; 147(1-2):52-3. PubMed ID: 15704574
[No Abstract] [Full Text] [Related]
17. Risedronate treatment and extended fracture protection in postmenopausal women.
Harris ST
Clin Exp Rheumatol; 2001; 19(6):625-6. PubMed ID: 11791630
[No Abstract] [Full Text] [Related]
18. Canadian consensus on osteoporosis. Preventing osteoporosis among postmenopausal women.
Can Fam Physician; 2003 Apr; 49():487. PubMed ID: 12729244
[No Abstract] [Full Text] [Related]
19. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
Ettinger MP
Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
[TBL] [Abstract][Full Text] [Related]
20. [When osteoporosis first manifests itself. Without therapy the next fracture threatens].
MMW Fortschr Med; 2002 Apr; 144(14):54. PubMed ID: 12014286
[No Abstract] [Full Text] [Related]
[Next] [New Search]
